What is NDC 71205-060?

71205-060 is the product NDC for Naproxen, Naproxen 375 mg/1 tablet, delayed release, listed with the FDA by Proficient Rx LP. It has 8 package NDCs, shown above in 10- and 11-digit form.

Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naproxen?

189 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naproxen NDC 71205-060 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-060Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0060Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-060-14	7120500601471205006014	14 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-14)Marketed from Jun 1, 2018
71205-060-15	7120500601571205006015	15 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-15)Marketed from Jun 1, 2018
71205-060-20	7120500602071205006020	20 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-20)Marketed from Jun 1, 2018
71205-060-30	7120500603071205006030	30 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-30)Marketed from Jun 1, 2018
71205-060-40	7120500604071205006040	40 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-40)Marketed from Jun 1, 2018
71205-060-45	7120500604571205006045	45 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-45)Marketed from Jun 1, 2018
71205-060-60	7120500606071205006060	60 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-60)Marketed from Jun 1, 2018
71205-060-90	7120500609071205006090	90 TABLET, DELAYED RELEASE in 1 BOTTLE (71205-060-90)Marketed from Jun 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen
Generic name (nonproprietary): naproxen
Active ingredients: Naproxen — 375 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Proficient Rx LPNDC labeler code 71205
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091432
Marketing start: Jul 5, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 71205-060_6b4c9ec2-308f-4b60-941c-34a2c7a7882cSPL ID 6b4c9ec2-308f-4b60-941c-34a2c7a7882cSPL set ID 69a3afd6-d64b-4f07-b848-b0d3fc19f2a2RxCUI 603103UNII 57Y76R9ATQ
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205006014 followed by a unit qualifier and the quantity

Package 71205-0060-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 1, 2019. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of naproxen delayed-release tablets and other treatment options before deciding to use naproxen delayed-release tablets. Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals ( see WARNINGS: Gastrointestinal Bleeding, Ulceration, and Perforation ). Naproxen delayed-release tablets are indicated: • For the relief of the signs and symptoms of rheumatoid arthritis • For the relief of the signs and symptoms of osteoarthritis • For the relief of the signs and symptoms of ankylosing spondylitis • For the relief of the signs and symptoms of juvenile arthritis Naproxen del…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71205-060

What is NDC 71205-060?: 71205-060 is the product NDC for Naproxen, Naproxen 375 mg/1 tablet, delayed release, listed with the FDA by Proficient Rx LP. It has 8 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naproxen.
What is the active ingredient?: Naproxen.
Who is the labeler?: Proficient Rx LP, NDC labeler code 71205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naproxen?: 189 other product NDCs are listed under this name. See all Naproxen NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Naproxen NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Naproxen	Naproxen 500 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-092	87441-0092-01
Naproxen	Naproxen 500 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-190	60760-0190-60
Naproxen	Naproxen 500 mg/1	TabletOral	REMEDYREPACK INC.	70518-4750	70518-4750-00
Naproxen	Naproxen 500 mg/1	TabletOral	Coupler LLC	67046-0784	67046-0784-03
Naproxen	Naproxen 250 mg/1	TabletOral	Coupler LLC	67046-0499	67046-0499-03
Naproxen	Naproxen 375 mg/1	TabletOral	Coupler LLC	67046-0500	67046-0500-03
Naproxen	Naproxen 500 mg/1	TabletOral	Coupler LLC	67046-0501	67046-0501-03
Naproxen	Naproxen 375 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-211	11534-0211-01
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-212	11534-0212-01
Naproxen	Naproxen 250 mg/1	TabletOral	REMEDYREPACK INC.	70518-4514	70518-4514-00

All 190 Naproxen NDCs

Other NDCs under ANDA 091432

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 091432
Product	Strength	Form · route	Labeler	Product NDC
Naproxen	Naproxen 375 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-211
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-212
Naproxen	Naproxen 375 mg/1	TabletOral	Cameron Pharmaceuticals	42494-453
Naproxen	Naproxen 500 mg/1	TabletOral	Cameron Pharmaceuticals	42494-454
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	NuCare Pharmaceuticals,Inc.	66267-373
Naproxen	Naproxen 375 mg/1	Tablet, Delayed releaseOral	Cipla USA Inc.	69097-851
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	Cipla USA Inc.	69097-852
Naproxen	Naproxen 375 mg/1	TabletOral	Bryant Ranch Prepack	72162-2275
Naproxen	Naproxen 500 mg/1	TabletOral	Bryant Ranch Prepack	72162-2276
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	PD-Rx Pharmaceuticals, Inc.	72789-003